Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
BJGP Open|August 8, 2025
Rising scabies incidence and the growing burden on general practitionersSaskia C van der Boor, Ines Figaroa, Annemarie A Uijen, et al.Frontiers in Cellular and Infection Microbiology|March 7, 2022
Mid-Liver Stage Arrest of Plasmodium falciparum Schizonts in Primary Porcine HepatocytesSaskia C van der Boor, Geert-Jan van Gemert, Alex E J Hanssen, et al.BMC Medicine|April 6, 2023
Whole sporozoite immunization with Plasmodium falciparum strain NF135 in a randomized trialSaskia C van der Boor, Manon Alkema, Geert-Jan van Gemert, et al.The Journal of Infectious Diseases|April 12, 2023
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria TransmissionJoseph D Challenger, Stijn W van Beek, Rob Ter Heine, et al.The Lancet. Infectious Diseases|August 13, 2022
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adultsSaskia C van der Boor, Merel J Smit, Stijn W van Beek, et al.Science Translational Medicine|May 22, 2020
A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1Meta Roestenberg, Jona Walk, Saskia C van der Boor, et al.Pageof 1